EVENTI ATMP FORUM

EVENTI CONSIGLIATI

12-15 Mag, 2021
Portland, USA

AMERICAN SOCIETY OF GENE AND CELL THERAPY (ASGCT) 24TH ANNUAL MEETING

Visualizza tutti >>

Regolatorio

In questa sezione è riportato l’archivio completo delle notizie sulle ATMP, suddivise per area di interesse

Regolatorio

Business

Pricing

Clinica

Altro

PLURISTEM THERAPEUTICS ANNOUNCES FDA ORPHAN DRUG DESIGNATION FOR PLX CELL THERAPY FOR THE TREATMENT OF GRAFT FAILURE AND INCOMPLETE RECOVERY FOLLOWING HEMATOPOIETIC CELL TRANSPLANTATION

Data: 25 Set, 2018

Fonte: "https://www.nasdaq.com/"

MESOBLAST HEART FAILURE CELL THERAPY FOR CHILDREN FEATURED AT REGENERATIVE SYMPOSIUM FOR CONGENITAL HEART DISEASE

Data: 25 Set, 2018

Fonte: "https://www.nasdaq.com"

FDA LIFTS HOLDS ON EPIZYME CANCER CANDIDATE, SAREPTA DMD GENE THERAPY

Data: 24 Set, 2018

Fonte: "https://www.genengnews.com"

STEM CELL THERAPY INTRODUCED IN OMAN

Data: 24 Set, 2018

Fonte: "https://www.muscatdaily.com"

CELL THERAPY REJECTED FOR AGGRESSIVE ADULT LYMPHOMA ON THE NHS

Data: 24 Set, 2018

Fonte: "https://www.europeanpharmaceuticalreview.com"

NEW GENE THERAPY FOR RARE INHERITED DISORDER CAUSING VISION LOSS RECOMMENDED FOR APPROVAL

Data: 21 Set, 2018

Fonte: "http://www.ema.europa.eu"

CELL AND GENE THERAPY CATAPULT CENTRE GETS GREEN LIGHT

Data: 11 Set, 2018

Fonte: "https://www.cleanroomtechnology.com"

GENE THERAPY FOR MODERATE TO SEVERE LOCALIZED SCLERODERMA GRANTED FAST TRACK DESIGNATION

Data: 5 Set, 2018

Fonte: "https://www.raredr.com"

LUXTURNA RETINAL GENE THERAPY COULD CURE BLINDNESS CAUSED DUE TO FAULTY GENES

Data: 5 Set, 2018

Fonte: "https://www.theweek.in"

TARGETED STAKEHOLDER CONSULTATION ON THE DRAFT GUIDELINES ON GOOD CLINICAL PRACTICE FOR ADVANCED THERAPY MEDICINAL PRODUCTS

Data: 5 Set, 2018

Fonte: "https://ec.europa.eu"

APPROVAZIONE EUROPEA DELLE TERAPIE CAR-T, IL COMMENTO DI ALLEANZA CONTRO IL CANCRO

Data: 4 Set, 2018

Fonte: "https://www.osservatoriomalattierare.it"

CONFERENCE TO ADDRESS ASEPTIC MANUFACTURING CHALLENGES OF ATMPS

Data: 29 Ago, 2018

Fonte: "https://www.cleanroomtechnology.com"

TERAPIE CAR-T CONTRO I TUMORI. DE MARIA (ACC): “NELLA RETE ONCOLOGICA NAZIONALE PROGETTI MOLTO PROMETTENTI”

Data: 28 Ago, 2018

Fonte: "http://www.quotidianosanita.it"

ORPHAN DRUG DESIGNATION GRANTED TO BIETTI'S CRYSTALLINE DYSTROPHY GENE THERAPY

Data: 28 Ago, 2018

Fonte: "https://www.raredr.com"

CAR-T, VIA LIBERA IN EUROPA ALLE PRIME TERAPIE CELLULARI PER I TUMORI

Data: 27 Ago, 2018

Fonte: "http://www.repubblica.it"

GENE THERAPY CANDIDATE GRANTED FAST TRACK DESIGNATION FOR TREATMENT OF ACHROMATOPSIA

Data: 20 Ago, 2018

Fonte: "https://www.raredr.com"

OFFICIALS REMOVE SPECIAL RULES FOR GENE THERAPY EXPERIMENTS

Data: 15 Ago, 2018

Fonte: "https://www.heraldnet.com"

THE POTENTIAL OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE

Data: 2 Ago, 2018

Fonte: "https://www.healtheuropa.eu"

ALL’EMA IL DOSSIER SULLA PRIMA TERAPIA GENICA CONTRO LA Β-TALASSEMIA

Data: 2 Ago, 2018

Fonte: "https://it.blastingnews.com"

FDA SEEKS TO ENHANCE MANUFACTURING OF CELL AND GENE THERAPIES

Data: 2 Ago, 2018

Fonte: "http://www.biopharminternational.com"

FDA AND EMA TO HOLD WORKSHOP ON BREAKTHROUGH AND PRIME DESIGNATIONS

Data: 31 Lug, 2018

Fonte: "https://www.raps.org"

GENE THERAPY FROM BLUEBIRD BIO GETS ACCELERATED ASSESSMENT BY CHMP

Data: 31 Lug, 2018

Fonte: "https://www.epmmagazine.com"

FDA ANNOUNCES NEW FRAMEWORK FOR GENE THERAPIES TO TREAT RARE DISEASES

Data: 29 Lug, 2018

Fonte: "https://www.ajmc.com"

BLUEBIRD’S FIRST GENE THERAPY GETS EUROPEAN FAST TRACK

Data: 27 Lug, 2018

Fonte: Date: Jul 27, 2018
Source: http://www.pmlive.com"

More...

BLUEBIRD BIO’S LENTIGLOBIN™ GENE THERAPY GRANTED ACCELERATED ASSESSMENT BY EUROPEAN MEDICINES AGENCY FOR THE TREATMENT OF TRANSFUSION-DEPENDENT Β-THALASSEMIA

Data: 26 Lug, 2018

Fonte: "https://www.businesswire.com/"

FDA LAYS DOWN THE LAW ON GENE THERAPY, OFFERING GUIDANCES ON BOTH DISEASES AND PROCEDURES

Data: 12 Lug, 2018

Fonte: "https://endpts.com/"

NINE MEDICINES RECOMMENDED FOR APPROVAL, INCLUDING THE FIRST TWO CAR-T CELL THERAPIES IN THE EU

Data: 29 Giu, 2018

Fonte: "http://www.ema.europa.eu/ema/"

EUROPEAN CHMP ADOPTS POSITIVE OPINION FOR YESCARTA® (AXICABTAGENECILOLEUCEL) FOR THE TREATMENT OF RELAPSED OR REFRACTORY DLBCL ANDPMBCL, AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY

Data: 29 Giu, 2018

Fonte: "http://www.businesswire.com"

Pagina 5 di 6

SCIENCE THROUGH NETWORKING

EVENTI ATMP FORUM

EVENTI CONSIGLIATI

Visualizza tutti >>

Regolatorio

In questa sezione è riportato l’archivio completo delle notizie sulle ATMP, suddivise per area di interesse

Regolatorio

Business

Pricing

Clinica

Altro

More...